Unknown

Dataset Information

0

A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features.


ABSTRACT: Gastritis is an inflammation of the gastric mucosa. In this study, we investigated the efficacy of a medical device, Esoxx®, based on hyaluronic acid and chondroitin sulfate on gastritis-related upper abdominal pain/discomfort and endoscopic features. Fifty patients, affected by gastritis, were randomised to receive the medical device or placebo. The primary endpoint was the medical device efficacy on upper abdominal pain/discomfort associated with gastritis and measured by Visual Analogue Scale (VAS). The secondary endpoints were the efficacy of the medical device on gastritis-related mucosal erosions, blood oozing, and hyperemia (redness)/edema, as assessed by endoscopy, and the patients' rating of their compliance with the treatments. A significant reduction in VAS pain was observed in the treatment group after a 5-week treatment, if compared with placebo (p < 0.001). In summary, administration of a medical device, based on hyaluronic acid and chondroitin sulfate, improves gastritis-related upper abdominal pain/discomfort and decreases mucosal erosions, blood oozing, and hyperemia (redness)/edema at 5-week follow-up in patients affected by gastritis.

SUBMITTER: Iannitti T 

PROVIDER: S-EPMC6133073 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features.

Iannitti Tommaso T   Morales-Medina Julio César JC   Merighi Alberto A   Boarino Valentina V   Laurino Carmen C   Vadalà Maria M   Palmieri Beniamino B  

Drug delivery and translational research 20181001 5


Gastritis is an inflammation of the gastric mucosa. In this study, we investigated the efficacy of a medical device, Esoxx®, based on hyaluronic acid and chondroitin sulfate on gastritis-related upper abdominal pain/discomfort and endoscopic features. Fifty patients, affected by gastritis, were randomised to receive the medical device or placebo. The primary endpoint was the medical device efficacy on upper abdominal pain/discomfort associated with gastritis and measured by Visual Analogue Scale  ...[more]

Similar Datasets

| S-EPMC1305620 | biostudies-literature
| S-EPMC2941170 | biostudies-literature
| S-EPMC10245839 | biostudies-literature
| S-EPMC9498617 | biostudies-literature
| S-EPMC8924925 | biostudies-literature
| S-EPMC6688722 | biostudies-literature
| PRJNA1223101 | ENA
| PRJNA1238194 | ENA
| PRJNA1265092 | ENA
| PRJNA1235994 | ENA